Back9 résultats
GridList
Thumbnail

Oral microbiome’s impact on mucositis and locoregional tumor control in HNSCC patients undergoing radiotherapy

Thumbnail

Influence of chemotherapy regimens prior to nivolumab on the survival of recurrent/metastatic SCCHN.

Thumbnail

Pembrolizumab plus platinum and taxanes as first-line and as neoadjuvant/induction therapies in PF-unfit patients with PDL1-positive squamous cell carcinoma of the head and neck

Thumbnail

Real world data on Low-Dose Nivolumab with Triple Metronomic Chemotherapy: Retrospective analysis of 50 consecutive patients from LMICs

Thumbnail

Efficacy of nivolumab versus pembrolizumab in rmHNSCC. A prospective national multicenter study.

Thumbnail

Efficacy and Safety of Salvage Chemotherapy After Progression to Anti-PD(L)1 Agents in Patients with Recurrent/Metastatic Head and Neck Cancer

Thumbnail

EFFICACY AND SAFETY OF CHEMO-IMMUNOTHERAPY IN RECURRENT/METASTATIC HNSCC: A RETROSPECTIVE ANALYSIS

Thumbnail

Head and neck cancers with synchronous primary cancers in Ireland

Thumbnail

Baseline Hemoglobin as an independent marker for survival outcome in squamous cell carcinoma of head and neck- An institutional review from tertiary cancer centre